Prostatic adenoma

Summary

Prostatic adenoma (MONDO:0002450) is a cancer and 6 clinical trials. A subtype of adenoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	prostatic adenoma
Mondo ID	MONDO:0002450
DOID	DOID:2883
NCIT	C4795
SNOMED CT	21173002
UMLS	C0520477
MedGen	105447
Anatomy (UBERON)	UBERON:0002367
Is cancer (heuristic)	yes

Also known as: adenoma of the prostate · prostate gland adenoma

Disease family

This is a subtype of adenoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › adenoma › prostatic adenoma

Related subtypes (30): villous adenoma, breast adenoma, minor vestibular glands adenoma, cystadenoma, sebaceous adenoma, renal adenoma, papillary adenoma, Bartholin gland adenoma, mixed cell adenoma, lung adenoma, middle ear adenoma, oncocytic adenoma, clear cell adenoma, lipoadenoma, water-clear cell adenoma, vaginal adenoma, microcystic adenoma, rete testis adenoma, adrenal cortex adenoma, follicular thyroid adenoma, ovarian adenoma benign, digestive system adenoma, mixed somatotroph-lactotroph pituitary gland adenoma, pituitary gland adenoma, parathyroid gland adenoma, hepatocellular adenoma, adenoma of pancreas, sweat gland adenoma, tubular adenoma, tubulovillous adenoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 6.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	5
PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04693507	PHASE2	COMPLETED	Teverelix Evaluated in Advanced Prostate Cancer
NCT02940392	Not specified	COMPLETED	Rezum FIM Optimization Study
NCT02940977	Not specified	UNKNOWN	Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
NCT02943070	Not specified	COMPLETED	Rezum I Pilot Study for Benign Prostatic Hyperplasia
NCT05157724	Not specified	WITHDRAWN	Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
NCT05687019	Not specified	COMPLETED	Efficacy of Hyaluronic Acid Injections on Functional Recovery After Surgery for Prostate Adenoma